Searched for
MERIL
PRISM-PCI Conclave 2026 in Vapi highlights India’s evolving approach to heart careThe PRISM-PCI Conclave 2026 highlighted India's significant advancements in cardiac care, showcasing its evolution from a consumer to a con...- Meril’s Mizzo Endo 4000 sets a new benchmark in robotic surgeryMeril, an Indian medical device company, has launched the Mizzo Endo 4000, a next-generation surgical robotic system. This advancement aims...
- ADIA signs a definitive agreement to invest $200 million in medical devices firm MerilAbu Dhabi Investment Authority (ADIA) is set to invest $200 million for a 3% stake in medical device maker Meril, valuing the company at $6...
- Abu Dhabi Investment Authority to buy 3% stake in Micro Life Sciences for $200 mnAbu Dhabi Investment Authority (ADIA) is set to acquire a 3% stake in the Indian medical device company, Micro Life Sciences Pvt Ltd (Meril...
- Warburg-backed Micro Life eyes $150 mn in pre-IPO round; eyes $5 bn valuationMicro Life Sciences, India's largest medical devices group, is seeking to raise $150 million by selling a small stake, aiming for a $5 bill...
- PM Modi inaugurates infrastructural projects worth over Rs 280 crore in GujaratPrime Minister Narendra Modi inaugurated projects and tourist attractions in Ekta Nagar, Gujarat worth Rs 284 crore to boost tourism, acces...
- Govt mulls over new category for advanced coronary stents, price ceiling increase to attract manufacturersThe government is considering creating a separate category for advanced coronary stents and raising the price ceiling to attract stent make...
- Warburg Pincus to invest $ 210 million in medical devices firm MerilThe US private equity firm will be acquiring the shares through Warburg Pincus, through its Dutch affiliate South Elm Investments B.V., and...
- CCMB ties up with Meril to produce dry swab-based RT-PCR test kitsMeril is currently equipped to manufacture 2 crore kits a month where each kit suffices for 100 tests. Each test will cost Rs 45-60, the co...
- Meril receives nod from ICMR for its indigenous COVID-19 self-test kitThe company's indigenous home-use rapid antigen test kits 'CoviFind' will expand access to Covid-19 testing, while also helping the nation ...
- Meril Life Sciences launches indigenously developed bioresorbable scaffoldThis novel therapy option, which can meaningfully treat an identified subset of the patient population, will be launched in a phased, seque...
- Drug price regulator exempts Meril Life Sciences from price controls for a stent developed 3 years agoThis means that the firm has provided adequate justification to the government for launching its product at “any price" it wants. Meril Lif...
- NPPA defers decision on Meril’s stent pricing pleaMeril Life’s first locally made biodegradable cardiac scaffold, a naturally dissolving stent, is known as MeRes100. The stent was approved ...
- Patients' group opposes stent categorisationIn April 2015 and January 2018, expert committees examining the request for separate categories for 'innovative' stents had decided that th...
- With general elections nearing, mobile tariff may not rise: ReportMobile tariffs for subscribers are not expected to increase with general elections coming next year in May, according to a report by Bank o...
- First India-made dissolvable stent gets ministry nodUnlike drug-eluting stents that are made of metal and stay in the arteries forever, Meril’s 100 micron-thick BVS ‘MeRes100’ is made of mate...
- BofA-ML trims India's FY14 GDP forecast yet again to 5.8 per centBank of America Merill Lynch (BofA-ML) on Monday lowered India's GDP growth projection yet again, saying the economy will expand at 5.8%
- Merill Lynch maintains 'buy' for Reliance IndustriesMerill Lynch has cut its price objective on Reliance Industries (RIL) by 15% from Rs 1,825 to Rs 1,555 based on sum of the parts valuation.
- Fitch places debentures of DSP Merrill Lynch on WatchGlobal rating agency Fitch on Friday placed DSP Merrill Lynch Capital Ltd's Rs 1,500-crore guaranteed long-term debenture programme on Rati...
- Merill Lynch maintains 'underperform' ratings on BalajiMerill Lynch has maintained its "underperform" ratings on Balaji Telefilms.
Load More
